Human Subjects with RRMS
A study including 165 patients with relapsing-remitting multiple sclerosis (RRMS) found that high treatment satisfaction and good communication with physicians were linked to better self-reported adherence to disease-modifying therapies (DMTs). Conversely, higher disability levels correlated with decreased adherence.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not yet assessed
- Mechanism
- Not yet assessed
- Evidence strength
- Not yet assessed
- Outcome
- Not yet assessed
Why it matters
Understanding the factors influencing adherence can help improve treatment outcomes for patients with RRMS, emphasizing the importance of effective communication and patient satisfaction.
What this does not prove
This cross-sectional study cannot determine cause and effect and was conducted at a single center, limiting the ability to generalize findings to wider populations.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Observational
- Participants / samples
- 165 · basis not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Yes
- Relevant MS type
- RRMS
- Publication date
- 2026-10-09
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
Supporting passages (10)
study designMATERIAL AND METHODS: This cross-sectional online survey study included 165 patients with RRMS (67.27% women), with mean age 44.42 ± 10.43 years, treated at the Department of Neurology, Wroclaw Medical University.
subjectsMATERIAL AND METHODS: This cross-sectional online survey study included 165 patients with RRMS (67.27% women), with mean age 44.42 ± 10.43 years, treated at the Department of Neurology, Wroclaw Medical University.
sample sizeMATERIAL AND METHODS: This cross-sectional online survey study included 165 patients with RRMS (67.27% women), with mean age 44.42 ± 10.43 years, treated at the Department of Neurology, Wroclaw Medical University.
primary endpoint metPURPOSE: The aim of the study was to evaluate self-reported adherence to therapeutic recommendation among patients with RRMS and to examine its associations with treatment satisfaction and physician-patient communication.
relevant ms typesMATERIAL AND METHODS: This cross-sectional online survey study included 165 patients with RRMS (67.27% women), with mean age 44.42 ± 10.43 years, treated at the Department of Neurology, Wroclaw Medical University.
interventionBACKGROUND: Adherence to disease modifying therapies (DMTs) is essential for treatment outcomes in relapsing-remitting multiple sclerosis (RRMS).
primary endpointPURPOSE: The aim of the study was to evaluate self-reported adherence to therapeutic recommendation among patients with RRMS and to examine its associations with treatment satisfaction and physician-patient communication.
findingsCONCLUSION: In this single-centre cross-sectional sample of patients with RRMS, higher self-reported treatment satisfaction and more favourable ratings of physician-patient communication were associated with modestly higher self-reported adherence scores, while greater disability was associated with lower adherence.
publication datePublication date: 2026-10-09
limitationsTitle: Association of Physician-Patient Communication and Treatment Satisfaction with Adherence to Disease-Modifying Therapies Among Patients with Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional Study.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.